Refik Pul

9PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)GlycoconjugatesAutoimmunityOptometry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 18, 2026
Treatment-free remission in MS: long-term disease control with cladribine tablets.

Heinz Wiendl, Ralf Gold, Refik Pul

|Nov 27, 2025
Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapy.

C Kleinschnitz, T Skripuletz, S Pfeuffer

|Oct 27, 2025
A narrative review on the safety of glatiramer acetate in multiple sclerosis: focus on Europe.

Refik Pul, Jelena Skuljec, Santosh B Shirol

|Sep 03, 2025
The impact of autoimmune comorbidities on multiple sclerosis progression: insights from a longitudinal single-center study.

Derya Aslan, Sabrina Bourabia, Bernd Kowall

|Oct 11, 2024
Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disease.

Ann-Kathrin Kogel, Theodoros Ladopoulos, Carolin Schwake

|Oct 01, 2024
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.

Marius Ringelstein, Susanna Asseyer, Gero Lindenblatt

Pageof 2

Frequent Collaborators

4 joint publications

Christoph Kleinschnitz

3 joint publications

Ralf Gold

2 joint publications

Thomas Skripuletz

2 joint publications

Orhan Aktas